Healthtech unicorn Innovaccer has accomplished an worker secondary buyback value Rs 600 crore (round $75 million), offering liquidity to present and former staff holding vested inventory choices, in accordance with an Inc42 report.

CEO Abhinav Shashank mentioned the buyback was aimed toward changing worker possession into tangible outcomes, at the same time as the corporate continues to take a position aggressively in its platform and clients.

“If persons are serving to construct long-term worth daily, they need to have the chance to take part in that worth alongside the best way. Liquidity and secondary buybacks are merely an extension of our perception in individuals, not simply as staff, however as long-term companions within the firm’s journey,” Shashank advised Inc42.

An ESOP buyback permits an organization to repurchase shares held by staff that originate from exercised inventory choices, providing liquidity with out issuing new shares or diluting current possession.

Based in 2014 by Shashank, Kanav Hasija and Sandeep Gupta, Innovaccer operates a healthcare information and analytics platform that helps hospitals, well being techniques and insurers unify medical, monetary and operational information. Its Healthcare Intelligence Cloud and Information Activation Platform combine info from digital well being data, claims and different techniques right into a single supply of fact.

The California-headquartered firm counts CommonSpirit Well being, Kaiser Permanente and Banner Well being amongst its key clients and has constructed a powerful footprint within the US healthcare market, working carefully with supplier networks and payers.

The buyback follows Innovaccer’s $275 million Sequence F funding spherical final 12 months, which comprised a mixture of major and secondary capital. The spherical noticed participation from B Capital Group, Banner Well being, Danaher Ventures LLC, Technology Funding Administration, Kaiser Permanente and M12. On the time, the corporate mentioned the capital could be deployed to gasoline enlargement, introduce new AI and cloud capabilities, and scale its developer ecosystem.

Since then, Innovaccer has stepped up mergers and acquisitions to deepen its product stack. In 2024, it acquired affected person expertise and CRM platform Cured and Pharmacy High quality Options, which focuses on pharmacy efficiency.

In September 2025, the corporate purchased AI-enabled specialty care startup Story Well being to strengthen specialty care administration, adopted by the acquisition of Humbi AI so as to add actuarial and contracting copilots.

Over the previous 12 months, Innovaccer has additionally rolled out three new merchandise. These embrace Innovaccer Gravity, a healthcare intelligence platform designed to assist organisations operationalise AI by unifying information, analytics and AI workflows; Movement, an AI-driven prior authorisation resolution aimed toward decreasing revenue-cycle friction and accelerating payer–supplier workflows; and Comet, an AI-powered entry centre that automates scheduling, inquiries and front-office interactions to enhance affected person entry.

For the monetary 12 months ended March 2025, Innovaccer reported working income of Rs 387.71 crore and a revenue of Rs 36.1 crore, underscoring its push in the direction of sustainable progress even because it expands by way of acquisitions and product launches.